Perflubutane

5 trials 2 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

5 Countries

Phase II/III

Phase II

Phase III/IV

Phase II/III: 2 Phase II: 2 Phase III/IV: 1

Sponsors using this IMP

Helse Bergen HF 2 GE Healthcare Limited 1 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 1 Kuopio University Hospital 1

All trials

5 total

Phase 4 Paediatric Study to Evaluate Sonazoid™ Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging. Pending

2023-505569-95-00 Phase III/IV 2 countries GE Healthcare Limited
Contrast enhanced ultrasound a novel technique in lymphatic imaging - A prospective study Pending

2024-519077-19-01 Phase II/III 1 country Kuopio University Hospital
SonoDOCc 2 Recruiting

2023-508500-38-00 Phase II 1 country Helse Bergen HF
Contrast-enhanced ultrasound for sentinel node detection in patients with melanoma, breast cancer or head & neck cancer Recruiting

2024-515259-40-00 Phase II/III 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
The role of sonoporation-enhanced treatment in patients with inoperable pancreatic cancer Ended

2024-512176-35-00 Phase II 1 country Helse Bergen HF

Showing 1–5 of 5 trials

← All drugs A–Z